Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic NephropathyZhiqin Zhang, Xiaoyan Wu|Diabetes Metabolic Syndrome and Obesity|2021Cited by 35